The precision visually controlled miniinvasive interventions in oncosurgery of the mammary gland (review of scientific literature and analysis of own experience)

Abstract

The precision visually controlled miniinvasive interventions in oncosurgery of the mammary gland (review of scientific literature and analysis of own experience)

Author Biographies

I. I. Smolanka, National Cancer Institute, Kyiv, Ukraine

Smolanka Ivan Ivanovich, MD, DSci, professor,
National Cancer Institute,
Scientific and Research Department of Breast Tumors of the its Reconstructive Surgery,
33/43, Lomonosova str., 03022, Kyiv, Ukraine;
tel.: +380442590186;
е-mail: iismolanka@gmail.com;
ORCID ID: 0000-0002-1737-7408

O. A. Aksonov, National Cancer Institute, Kyiv, Ukraine

Аksonov Oleksii Anatolyevich, MD, PhD, surgeon oncologist,
National Cancer Institute,
Scientific and Research Department of Breast Tumors of the its Reconstructive Surgery,
33/43, Lomonosova str., 03022, Kyiv, Ukraine;
tel.: +380442590186;
е-mail: aleax17@ukr.net;
ORCID ID: 0000-0002-3322-0718

O. G. Aksonova, Ukrainian Scientific–Practical Centre of Endocrinal Surgery and Transplantation of Endocrinal Organs and Tissues, Kyiv, Ukraine

Aksonova Olena Gennadievna, MD, PhD, radiologist,
Ukrainian Scientific and Practical Center for Endocrine Surgery and Transplantation of Endocrine Organs and Tissues,
Department of Radiation Diagnostics,
13а, Klovsky descent str., 01021 Kyiv, Ukraine;
tel.: +380442545462;
е-mail: lena_belon@ukr.net;
ORCID ID: 0000-0003-2150-7081

G. A. Bilonenko, Ukrainian Scientific–Practical Centre of Endocrinal Surgery and Transplantation of Endocrinal Organs and Tissues, Kyiv, Ukraine

Bilonenko Gennady Anatolyevich, MD, DSci, professor,
Ukrainian Scientific and Practical Center for Endocrine Surgery and Transplantation of Endocrine Organs and Tissues,
Department of Radiation Diagnostics,
13а, Klovsky descent str., 01021 Kyiv, Ukraine;
tel.: +380442545462;
е-mail: belonenko49@mail.ru;
ORCID ID: 0000-0002-4487-4071

References

Matikas A, Foukakis T, Bergh J. Minimally invasive tissue access as a tool for delivering personalized medicine  with focus on oncology. J Intern Med. 2019;285(4):395-7. doi: 10.1111/joim.12860.

Johnson MM. Full-field digital mammography and digital breast tomosynthesis. Radiol Technol. 2017;88(3):299M-319M. PMID: 28298592.

Zou L, Yu S, Meng T, Zhang Z, Liang X, Xie Y. A technical review of convolutional neural network-based mammographic breast cancer diagnosis. Comput Math Methods Med. 2019;2019:6509357. doi: 10.1155/2019/6509357.

Postevka ID. Suchasnyi stan problemy skryninhu raku molochnoi zalozy (ohliad literatury). Buk. med. visnyk. 2016;20(2):199-203. [In Ukrainian].

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018;68(4):297-316. doi: 10.3322/caac.21446.

Paepke S, Metz S, Brea Salvago A, Ohlinger R. Benign breast tumours -diagnosis and management. Breast Care (Basel). 2018;13(6):403-12. doi:10.1159/000495919.

Nalieskina LA, Luk’ianova NYu, Chekhun VF. Molekuliarno-henetychni zasady klinichnoi heterohennosti raku molochnoi zalozy (ohliad literatury). Onkolohiia. 2017;19(3):171-9. [In Ukrainian].

Rak molochnoi zalozy. Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy 2015. Akusherstvo. Hinekolohiia. Henetyka. 2015;(2):5-65. [In Ukrainian].

Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, et al. Breast Cancer Screening and Diagnosis, Version 3.2018,NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(11):1362-89. doi: 10.6004/jnccn.2018.0083.

Le EPV, Wang Y, Huang Y, Hickman S, Gilbert FJ. Artificial intelligencein breast imaging. Clin Radiol. 2019;74(5):357-66. doi: 10.1016/j.crad.2019.02.006.

Smolanka II, Aksonov OA, Aksonova OH, Bilonenko HA. Osoblyvosti diahnostyky i khirurhichnoho likuvannia vnutrishnoprotokovykh novoutvoren hrudnoi zalozy. Ukr. med. chasopys. 2019;(2/1):50-3. doi 10.32471/umj.1680-3051.130.141159. [In Ukrainian].

Lorek A, Śliwczyński A, Więckowska B, Stawowski B, Dagiel J, Gawrychowski J. Analysis of diagnostic methods for focal lesions in breast glands with use of open surgical biopsies and core-needle biopsies in Poland. Med Sci Monit. 2018;24:4974-81. doi: 10.12659/MSM.908658.

Waaijer L, van Diest PJ, Verkooijen HM, Dijkstra NE, van der Pol CC, Borel Rinkes IH, et al. Interventional ductoscopy in patients with pathological nipple discharge. Br J Surg. 2015;102(13):1639-48. doi: 10.1002/bjs.9950.

Farshid G, Gill PG. Contemporary indications for diagnostic open biopsy in women assessed for screen-detected breast lesions: A ten-year, single institution series of 814 consecutive cases. Breast Cancer Res Treat. 2017;162(1):49-58. doi: 10.1007/s10549-016-4087-2.

Rao R, Ludwig K, Bailey L, Berry TS, Buras R, Degnim A, et al. Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely(®) Campaign. Ann Surg Oncol. 2018;25(10):2795-800. doi:10.1245/s10434-018-6584-5.

Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: a systematic review and meta-analysis.Breast. 2017;31:157-66. doi: 10.1016/j.breast.2016.11.009.

Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J, Bogucevska M,Dobruch-Sobczak K. Fine-needle versus core-needle biopsy - which one to choose in preoperative assessment of focal lesions in the breasts? Literature review. J Ultrason. 2017;17(71):267-74. doi: 10.15557/JoU.2017.0039.

Verver D, Oude Ophuis CMC, Koppert LB, de Monyé C, van Deurzen CHM, Koljenović S, et al. Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial. Eur J Nucl Med Mol Imaging. 2018;45(11):1926-33. doi: 10.1007/s00259-018-4014-3.

Franzén B, Alexeyenko A, Kamali-Moghaddam M, Hatschek T, Kanter L, Ramqvist T, et al. Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer. Mol Oncol. 2019;13(2):376-91. doi: 10.1002/1878-0261.12410.

Calhoun BC. Core needle biopsy of the breast: an evaluation of contemporary data. Surg Pathol Clin. 2018;11(1):1-16. doi: 10.1016/j.path.2017.09.001.

Rominger MB, Martini K, Dappa E, Puippe G, Klingmüller V, Frauenfelder T, et al. Ultrasound needle visibility in contrast mode imaging: an in vitro and ex vivo study. Ultrasound Int Open. 2017;3(2):E82-E88. doi: 10.1055/s-0043-101511.

Bilonenko HA, Siedakov IIe, Aksonov OA, Aksonova OH, Sukhina NO, Khlopushin YeIu, Starushko RV, vynakhidnyky; Bilonenko HA, Siedakov IIe, Aksonov OA, Aksonova OH, Sukhina NO, Khlopushin YeIu, Starushko RV, patentovlasnyky. Sposib prytsilnoi stereotaksychnoi trepan-biopsii renthenonehatyvnykh vnutrishnoprotokovykh novoutvoren hrudnoi zalozy. Pat. 119847 Ukrainy. 2017 Zhov 10. [In Ukrainian].

Yuan Z, Qu X, Zhang ZT, Jiang WG. Application of localization and needle placement guided by mammographic, ultrasound and fiber optic ductoscopy for resection of non-palpable breast lesions. Anticancer Res. 2017;37(8):4523-7. doi: 10.21873/anticanres.11849.

Uchida K, Toriumi Y, Kawase K, Tabei I, Yamashita A, Nogi H. Percutaneous endoscopy-guided biopsy of an intracystic tumor with a mammary ductoscopy. Breast Cancer. 2007;14(2):215-8. PMID: 17485908.

Richter H, Hennigs A, Schaefgen B, Hahn M, Blohmer JU, Kümmel S, et al. Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy? Geburtshilfe Frauenheilkd. 2018;78(1):48-53. doi: 10.1055/s-0043-124082.

Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev. 2015;(12):CD009206. doi:10.1002/14651858.CD009206.pub2.

Alamdaran SA, Farokh D, Haddad AS, Daghighi N, Modoodi E, Sadeghi R, et al. Assessment of Ultrasound / Radio-guided Occult Lesion Localization in Non-palpable Breast Lesions. Asia Ocean J Nucl Med Biol. 2018;6(1):10-4. doi: 10.22038/aojnmb.2017.9898.

Cox CE, Garcia-Henriquez N, Glancy MJ, Whitworth P, Cox JM, Themar-Geck M, et al. Pilot Study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions. Ann Surg Oncol. 2016; 23(6):1824-30. doi: 10.1245/s10434-015-5079-x.

Harvey JR, Lim Y, Murphy J, Howe M, Morris J, Goyal A, et al. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study. Breast Cancer Res Treat. 2018;169(3):531-6. doi: 10.1007/s10549-018-4709-y.

Merrill AY, Ochoa D, Klimberg VS, Hill EL, Preston M, Neisler K, et al. Cutting healthcare costs with hematoma-directed ultrasound-guided breast lumpectomy. Ann Surg Oncol. 2018;25(10):3076-81. doi: 10.1245/s10434-018-6596-1.

Reimer T, Engel J, Schmidt M, Offersen BV, Smidt ML, Gentilini OD. Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery? Breast Care (Basel). 2018;13(5):324-30. doi: 10.1159/000491703.

Qi XW, Du JZ, Tang P, Liu X, He QQ, Zhong L, et al. Clinical significance of internal mammary lymph node metastasis for breast cancer: Analysis of 337 breast cancer patients. Surg Oncol. 2018;27(2):185-91. doi: 10.1016/j.suronc.2018.03.006.

Chua CYX, Jain P, Susnjar A, Rhudy J, Folci M, Ballerini A, et al. Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer. J Control Release. 2018;285:23-34. doi: 10.1016/j.jconrel.2018.06.035.

Sanderink WBG, Mann RM. Advances in breast intervention: where are we now and where should we be? Clin Radiol. 2018;73(8):724-34. doi: 10.1016/j.crad.2017.10.018.

Mauri G, Sconfienza LM, Pescatori LC, Fedeli MP, Alì M, Di Leo G, et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis. Eur Radiol. 2017;27(8):3199-210. doi: 10.1007/s00330-016-4668-9.

Kinoshita T. RFA experiences, indications and clinical outcomes. Int J Clin Oncol. 2019;24(6):603-7. doi: 10.1007/s10147-019-01423-z.

Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, et al. A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016;23(8):2438-45. doi: 10.1245/s10434-016-5275-3.

Bilonenko GA, Uspenskyi DA. Novitni pidkhody do khirurhichnoho likuvannia vnutrishnoprotokovykh papilom molochnykh zaloz. Zbirnyk naukovykh prats KMAPO im. P. L. Shupyka. 2001;10,(4):1056-61.

Lee J, Park HY, Kim WW, Jeong JY, Lee YD, Choi MH, et al. Combination treatment with photodynamic therapy and laser ablation in breast cancer: an animal model study. Photomed Laser Surg. 2017;35(9):505-12. doi: 10.1089/pho.2017.4291.

Knuttel FM, van den Bosch MA, Young-Afat DA, Emaus MJ, van den Bongard DH,Witkamp AJ, et al. Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer. Value Health. 2017;20(3):474-80. doi: 10.1016/j.jval.2016.10.013.

Waaijer L, van Diest PJ, Verkooijen HM, Dijkstra NE, van der Pol CC, Borel Rinkes IH, et al. Interventional ductoscopy in patients with pathological nipple discharge. Br J Surg. 2015;102(13):1639-48. doi: 10.1002/bjs.9950.

de Boorder T, Waaijer L, van Diest PJ, Witkamp AJ. Ex vivo feasibility study of endoscopic intraductal laser ablation of the breast. Lasers Surg Med. 2018;50(2):137-42. doi: 10.1002/lsm.22745.

Gu Z, Al-Zubaydi F, Adler D, Li S, Johnson S, Prasad P, Holloway J, Szekely Z, et al. Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats. J Interdiscip Nanomed. 2018;3(3):146-59. doi: 10.1002/jin2.51.

Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, et al. Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med. 2011;3(106):106ra108. doi: 10.1126/scitranslmed.3002368.

Zhang B, Love SM, Chen G, Wang J, Gao J, Xu X, et al. The safety parameters of the study on intraductal cytotoxic agent delivery to the breast before mastectomy. Chin J Cancer Res. 2014;26(5):579-87. doi:10.3978/j.issn.1000-9604.2014.10.06.

Published
2019-09-28
How to Cite
Smolanka, I. I., Aksonov, O. A., Aksonova, O. G., & Bilonenko, G. A. (2019). The precision visually controlled miniinvasive interventions in oncosurgery of the mammary gland (review of scientific literature and analysis of own experience). Klinicheskaia Khirurgiia, 86(9), 59-64. https://doi.org/10.26779/2522-1396.2019.09.59